This inventor holds 63 USPTO granted patents and 19 published patent applications, plus 6 CIPO patents and 14 EPO patents, primarily in Alkaline Phosphatase (CPC class A61K). Top assignees: Synthetic Biologics, Inc., Novartis Ag, Theriva Biologics, Inc.. Active years: 1999-2026.
Inventors with similar research interests:
Location History:
- Potomac, MD (US) (2006 - 2012)
- Rockville, MD (US) (1999 - 2024)
Company Filing History:
24 out of 39 
15 out of 3,973 
12 out of 13 Years Active: 1999-2026
Areas of Expertise:
Title: Michael Kaleko: A Pioneer in Patent Innovations
Introduction
Michael Kaleko is an accomplished inventor based in Rockville, MD, with an impressive portfolio of 57 patents. His work focuses on innovative formulations that address critical therapeutic needs, particularly in the field of biotechnology and pharmaceuticals.
Latest Patents
Among his recent inventions are two groundbreaking patents. The first, titled "Beta-lactamase formulations and uses thereof," highlights the development of modified-release formulations containing beta-lactamase, designed to deliver substantial amounts of the enzyme in the intestines for therapeutic applications. The second patent, "Alkaline phosphatase formulations," outlines similar innovative modified-release powder formulations comprising an alkaline phosphatase-based agent, which also targets intestinal release for therapeutic benefits.
Career Highlights
Kaleko has made significant contributions through his roles at leading companies such as Synthetic Biologics, Inc. and Novartis AG. His tenure at these organizations has allowed him to develop and refine his expertise in creating novel medical formulations that meet pressing health challenges.
Collaborations
Throughout his career, Michael Kaleko has had the opportunity to collaborate with talented individuals like Sheila Connelly and Tianci Luo. These partnerships have been instrumental in advancing his research and patent innovations in the field.
Conclusion
Michael Kaleko's dedication to innovation in biopharmaceutical formulations is evident through his numerous patents and collaborative efforts. As a leading inventor, he continues to make a remarkable impact in the field, contributing to advancements that enhance therapeutic outcomes for patients.